Mayne Pharma Group Limited
MYX.ASXHealth Care
Develops, manufactures and markets pharmaceutical products globally
Market Data
$2.400
-0.0%$195.0M
-100000.0x
$-1.038
0.00%
-0.4%
Recent Announcements
Ceasing to be a substantial holder
Citigroup Global Markets Australia Pty Limited (ACN 003 114 832) ceased to be a substantial holder.
Becoming a substantial holder
Citigroup Global Markets Australia Pty Limited (ACN 003 114 832) became a substantial holder (5.0762%).
Becoming a substantial holder
Funicular Funds, LP became a substantial holder of Mayne Pharma Group Limited on 20 March 2026, acquiring a 6.30% voting power (5,115,240 shares) through purchases from TD Securities (USA), UBS AG, and Interactive Brokers totaling approximately $4.67 million across multiple transactions between November 2025 and March 2026.
Ceasing to be a substantial holder
Citigroup Global Markets Australia Pty Limited (ACN 003 114 832) ceased to be a substantial holder.
Becoming a substantial holder
Citigroup Global Markets Australia Pty Limited (ACN 003 114 832) became a substantial holder (5.8862%).
Becoming a substantial holder
Trium Capital LLP (Trium Capital), Trium Khartes Master Fund Limited (TKMFL), Chi-Rho Multi-Strategy Master Fund Ltd (Chi-Rho), AIS Acadia Master Fund Ltd (AIS), Maple Leaf Patriot Core LLC (MLPC), Eagle Harbor Multi-Strategy Master became a substantial holder (5.02%).
Ceasing to be a substantial holder from MUFG
MUFG ceased to be a substantial holder.
Ceasing to be a substantial holder
First Sentier Group Limited ACN 630 725 558 ceased to be a substantial holder.
Get real-time alerts for MYX
Receive AI-powered earnings summaries and instant notifications when Mayne Pharma Group Limited releases results.
Register Free